Investor Relations
Investor Relations
-
Current Price
HK$
18.06 -
YTD Closing Price
HK$
18 -
% Change
（0.33%）
0.06
Announcements & Circulars
-
032024.12
VOLUNTARY ANNOUNCEMENT APPROVAL FOR PACLITAXEL-ELUTING CORONARY BALLOON DILATATION CATHETER ACOART CAMELLIA BY PRC NATIONAL MEDICAL PRODUCTS ADMINISTRATION
-
022024.12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
-
222024.11
VOLUNTARY ANNOUNCEMENT APPROVAL FOR THE DELIVERY CATHETER FOR ASPIRATION CATHETER BY PRC NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Presentation
Presentation
Presentation
Corporate Governance
-
Ms. Jing LI
chairperson of the Board, Executive Director and Chief Executive Officer -
Mr. Silvio Rudolf
SCHAFFNERNon-executive Directors -
Mr. Arthur Crosswell BUTCHER
Non-executive Directors -
Ms. June CHANG
Non-executive Directors -
Dr. Yuqi WANG
Independent Non-executive Directors -
Ms. Hong NI
Independent Non-executive Directors -
Ms. Kin Yee POON
Independent Non-executive Directors
-
Ms. Jing LI
Chief Executive Officer -
Dr. Ulrich Reinhold
SPECKChief Technology Officer -
Ms. Weijia LI
Vice-president of Clinical and Regulations
-
282024-06
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Download -
122024-06
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Download -
162023-01
PROCEDURES FOR SHAREHOLDERS TO PROPOSE A PERSON FOR ELECTION AS A DIRECTOR OF THE COMPANY
Download -
162023-01
BOARD DIVERSITY POLICY
Download -
162023-01
SHAREHOLDERS’ COMMUNICATION POLICY
Download -
162023-01
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Download -
162023-01
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Download -
112023-01
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Download
